ARRY Crosses Above Average Analyst Target By: ETF Channel June 18, 2019 at 08:18 AM EDT In recent trading, shares of Array BioPharma Inc. (ARRY) have crossed above the average analyst 12-month target price of $31.55, changing hands for $46.44/share.. Read More >> Related Stocks: Array Technologies Inc